You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 4,252,721


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,252,721
Title: Cycloalkyltriazoles and process for obtaining same
Abstract:Compounds of the general formula: ##STR1## in which alk and alk' represent the bivalent radicals; aliphatic alkyl chains; and R and R' represent the alkyl, halogen, hydrogen, alkyloxy, --OH, --CF.sub.3 or --SCH.sub.3 radicals. Said compounds of the formula I are effective and useful as antiglaucomic and antipsychotic agents and also as additive agents in the withdrawal treatment of various addictive conditions. Methods for their preparation are also disclosed.
Inventor(s): Silvestrini; Bruno (Rome, IT), Baiocchi; Leandro (Rome, IT)
Assignee: Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. (Rome, IT)
Application Number:06/025,273
Patent Claim Types:
see list of patent claims
Compound;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patents: A Detailed Analysis

Introduction

Patents are a crucial component of intellectual property protection, allowing inventors and innovators to safeguard their creations and reap the benefits of their hard work. The United States Patent and Trademark Office (USPTO) plays a pivotal role in this process, ensuring that patents are granted to inventions that meet specific criteria. This article will delve into the scope and claims of U.S. patents, using the example of U.S. Patent 4,252,721 to illustrate key concepts.

What is a Patent?

A patent is a form of intellectual property that gives the patent holder the exclusive right to make, use, and sell an invention for a specified period, typically 20 years from the filing date of the patent application. Patents are granted for inventions that are novel, non-obvious, and useful[2].

The Patenting Process

The journey to obtaining a patent involves several steps:

  • Invention Disclosure: The inventor discloses the invention to the relevant authority, such as the KU Center for Technology Commercialization (KUCTC)[2].
  • Provisional Patent Application: A provisional patent application is often filed first, which allows the inventor to file a non-provisional application within one year[2].
  • Non-Provisional Patent Application: This is the formal application that includes detailed descriptions, drawings, and claims defining the invention.
  • Patent Prosecution: The patent examiner reviews the application, and the inventor may need to argue or amend claims to address any rejections[2].

Patent Claims

Importance of Claims

The claims section of a patent application is the most critical part, as it defines the boundaries of patent protection. Claims must be clear, concise, and specific to ensure that the invention is adequately protected[2].

Types of Claims

There are several types of claims, including:

  • Independent Claims: These stand alone and define the invention without reference to other claims.
  • Dependent Claims: These refer back to and further limit an independent claim.
  • Method Claims: These describe a process or method of achieving a particular result.
  • Apparatus Claims: These describe a device or system[2].

Patent Eligibility Criteria

For an invention to be patentable, it must meet the eligibility criteria set by the USPTO:

  • Novelty: The invention must be new and not previously known or used by others.
  • Non-Obviousness: The invention must be significantly different from existing technology and not obvious to a person with ordinary skill in the relevant field.
  • Usefulness: The invention must have a practical application or be capable of being used for a specific purpose[2].

The 2024 USPTO Guidance Update on AI Patents

Recent updates to the USPTO guidance have significant implications for AI-related inventions:

  • Integration into Practical Applications: The update emphasizes the importance of integrating judicial exceptions (such as abstract ideas) into practical applications. This involves assessing whether additional elements in the claim impose meaningful limits on the exception, transforming it into patent-eligible subject matter[1].
  • AI-Assisted Inventions: The guidance clarifies that the use of AI in the development of an invention does not affect its subject matter eligibility. Instead, the focus remains on the claimed invention itself, ensuring that AI-assisted inventions are evaluated equally with other technologies[1].
  • New Examples: The USPTO has introduced new examples specifically tailored to AI technologies, illustrating how claims involving AI can meet eligibility criteria by demonstrating concrete technological improvements[1].

Example Analysis: U.S. Patent 4,252,721

While U.S. Patent 4,252,721 is not an AI-related patent, analyzing its claims can provide insights into how patent claims are structured and evaluated.

Claim Structure

  • Independent Claims: These define the core aspects of the invention.
  • Dependent Claims: These further limit the independent claims, often adding specific details or features.

Claim Evaluation

Each claim must be evaluated against the patent eligibility criteria:

  • Novelty and Non-Obviousness: The claims must describe an invention that is new and not obvious to a person with ordinary skill in the field.
  • Usefulness: The claims must demonstrate a practical application or utility.

Real-World Applications and Practical Utility

Demonstrating real-world applications and practical utility is crucial for patent eligibility. For example, in the 2024 USPTO guidance update, Example 48 illustrates how specifying the use of separated audio components in a speech recognition system enhances the accuracy of voice commands, thereby meeting the criteria for patent eligibility[1].

International Patent Considerations

Patent protection is not limited to the United States. International patents can be filed, but the process and costs are more complex:

  • Filing Requirements: Different countries have different filing requirements and timelines.
  • Costs: International patents can be significantly more expensive than U.S. patents, often costing several times more than the $8,000 to $20,000 for a U.S. non-provisional patent application[2].

Patent Search and Prior Art

Before filing a patent application, it is essential to conduct a thorough patent search to ensure that the invention is novel and non-obvious:

  • Patent and Trademark Resource Centers (PTRCs): These centers provide local search resources and training in patent search techniques[4].
  • Common Citation Document (CCD): This tool consolidates prior art cited by multiple patent offices, helping to visualize search results for the same invention on a single page[4].

Patent Claims Research Dataset

The USPTO provides datasets that contain detailed information on claims from U.S. patents and patent applications. These datasets can be used to analyze trends and patterns in patent claims:

  • Data Files: The dataset includes individually-parsed claims, claim-level statistics, and document-level statistics, providing insights into patent scope and claim structure[3].

Key Takeaways

  • Clear and Specific Claims: Claims must be clear, concise, and specific to ensure adequate protection.
  • Practical Applications: Demonstrating real-world applications and practical utility is essential for patent eligibility.
  • International Considerations: International patents have different requirements and higher costs.
  • AI Inventions: AI-assisted inventions are evaluated based on the claimed invention itself, not the method of development.

FAQs

What are the main criteria for patent eligibility?

The main criteria are novelty, non-obviousness, and usefulness. The invention must be new, significantly different from existing technology, and have a practical application.

How do AI-related inventions impact patent eligibility?

AI-related inventions are evaluated based on the claimed invention itself, not the method of development. The focus is on whether the claim integrates a judicial exception into a practical application.

What is the importance of specifying real-world applications in patent claims?

Specifying real-world applications helps to transform abstract ideas into patent-eligible subject matter by demonstrating concrete technological improvements and practical utility.

How much does it cost to file a U.S. non-provisional patent application?

The cost can range between $8,000 and $20,000, depending on the complexity of the invention and the scope of previously prepared material.

What is the role of the Patent Claims Research Dataset?

The dataset provides detailed information on claims from U.S. patents and patent applications, allowing for the analysis of trends and patterns in patent claims and scope.

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
  2. Intellectual Property Protection - KU Office of Research
  3. Patent Claims Research Dataset - USPTO
  4. Search for patents - USPTO
  5. U.S. Patent Small Claims Court - ACUS

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 4,252,721

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 4,252,721

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Italy22421 A/78Apr 18, 1978

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.